Gene: ANKRD18B
Official Full Name: ankyrin repeat domain 18Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19847 | ANKRD18B Knockout cell line (HeLa) | Human | ANKRD18B | 1:3~1:6 | Negative | Online Inquiry |
KO19848 | ANKRD18B Knockout cell line (HCT 116) | Human | ANKRD18B | 1:2~1:4 | Negative | Online Inquiry |
KO19849 | ANKRD18B Knockout cell line (HEK293) | Human | ANKRD18B | 1:3~1:6 | Negative | Online Inquiry |
KO19850 | ANKRD18B Knockout cell line (A549) | Human | ANKRD18B | 1:3~1:4 | Negative | Online Inquiry |
ANKRD18B Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the expression of the ANKRD18B gene, which is implicated in various cellular processes, including cell proliferation, differentiation, and signaling pathways. This knockout model serves as a crucial tool for researchers studying gene function and regulatory mechanisms within cellular contexts. By eliminating the ANKRD18B gene, these cell lines enable scientists to elucidate the physiological consequences of its absence, offering insights into how this gene may be involved in diseases such as cancer and neurological disorders.
The underlying mechanism of these cell lines involves CRISPR-Cas9 technology, which facilitates precise genome editing and allows for the efficient disruption of the target gene. This contemporary approach ensures high specificity and a significant knockout efficiency, making it a reliable resource for functional genomics investigations. Researchers employing ANKRD18B knockout cell lines can thus perform mutation analysis, protein interaction studies, and other assays to decode the gene's role in health and disease.
The scientific importance of ANKRD18B Gene Knockout Cell Lines lies in their application across both basic research and translational medicine, providing insights that could lead to therapeutic discoveries. These models are invaluable in drug development, as they allow for the testing of pharmacological responses in a controlled genetic environment. Researchers can use these cell lines to identify potential drug targets and mechanisms of action, offering a path toward more effective treatments.
What sets our ANKRD18B Gene Knockout Cell Lines apart from competing products is their rigorous validation and characterization, ensuring robust reproducibility in experimental outcomes. Furthermore, they come with comprehensive technical support and documentation, facilitating their integration into diverse research protocols.
For researchers and clinicians alike, the value of ANKRD18B Gene Knockout Cell Lines is clear: they not only advance our understanding of gene function but also provide a foundation for innovative therapeutic strategies. Our company specializes in high-quality biological products, and with our expertise in genetic engineering and cell line development, we are committed to supporting the scientific community in unraveling complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.